Cargando…
Glycosylation Alterations in Cancer Cells, Prognostic Value of Glycan Biomarkers and Their Potential as Novel Therapeutic Targets in Breast Cancer
Although we are lately witnessing major improvements in breast cancer treatment and patient outcomes, there is still a significant proportion of patients not receiving efficient therapy. More precisely, patients with triple-negative breast cancer or any type of metastatic disease. Currently availabl...
Autores principales: | Peric, Luka, Vukadin, Sonja, Petrovic, Ana, Kuna, Lucija, Puseljic, Nora, Sikora, Renata, Rozac, Karla, Vcev, Aleksandar, Smolic, Martina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775348/ https://www.ncbi.nlm.nih.gov/pubmed/36552021 http://dx.doi.org/10.3390/biomedicines10123265 |
Ejemplares similares
-
The accuracy of breast cancer risk self-assessment does not correlate with knowledge about breast cancer and knowledge and attitudes towards primary chemoprevention
por: Bojanic, Kristina, et al.
Publicado: (2020) -
The Role of GLP1-RAs in Direct Modulation of Lipid Metabolism in Hepatic Tissue as Determined Using In Vitro Models of NAFLD
por: Petrovic, Ana, et al.
Publicado: (2023) -
Molecular Mechanisms of Resistance to Immune Checkpoint Inhibitors in Melanoma Treatment: An Update
por: Vukadin, Sonja, et al.
Publicado: (2021) -
Peptic Ulcer Disease: A Brief Review of Conventional Therapy and Herbal Treatment Options
por: Kuna, Lucija, et al.
Publicado: (2019) -
Preclinical Models and Promising Pharmacotherapeutic Strategies in Liver Fibrosis: An Update
por: Kolaric, Tea Omanovic, et al.
Publicado: (2023)